HomeStocks

IPD

ImpediMed Ltd

Director Trades

DateDirectorValue
F. Bones$49,276
C. Donnelly$15,915
C. Donnelly$36,911
C. Donnelly$9,519

Company News

ImpediMed’s BIS technology gains recognition as NCCN includes in oncology guidelines for lymphoedema assessment
Biotechnology

ImpediMed’s BIS technology gains recognition as NCCN includes in oncology guidelines for lymphoedema assessment

AstraZeneca sources ImpediMed’s SOZO devices for upcoming clinical trial
Technology

AstraZeneca sources ImpediMed’s SOZO devices for upcoming clinical trial

ImpediMed welcomes NCCN’s updated breast cancer guidelines to provide early lymphoedema screening
Biotechnology

ImpediMed welcomes NCCN’s updated breast cancer guidelines to provide early lymphoedema screening

ImpediMed offers first glimpse into PREVENT trial results
Biotechnology

ImpediMed offers first glimpse into PREVENT trial results

Company Videos

No videos found.